The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling

• Published in: Science (American Association for the Advancement of Science) Vol. 332; no. 6035; pp. 1317 - 1322
• Main Authors: Hsu, Peggy P., Kang, Seong A., Rameseder, Jonathan, Zhang, Yi, Ottina, Kathleen A., Lim, Daniel, Peterson, Timothy R., Choi, Yongmun, Gray, Nathanael S., Yaffe, Michael B., Marto, Jarrod A., Sabatini, David M.
• Format: Journal Article
• Language: English
• Published: United States American Association for the Advancement of Science 10-06-2011; The American Association for the Advancement of Science
• Subjects: Amino acids; Animals; Cell Line; Cellular biology; Gene expression regulation; GRB10 Adaptor Protein - metabolism; Growth factors; HeLa cells; Humans; Immunoblotting; Inhibition; Insulin; Insulin - metabolism; Intercellular Signaling Peptides and Proteins - metabolism; Kinases; Mass Spectrometry; Mechanistic Target of Rapamycin Complex 1; Mice; Multiprotein Complexes; Naphthyridines - pharmacology; Peptides; Phosphoproteins - metabolism; Phosphorylation; Physiological regulation; Proline; Proteins; Proteins - metabolism; Proteome - metabolism; Proteomics; Receptors; Signal Transduction; Signaling; Sirolimus - pharmacology; TOR Serine-Threonine Kinases - metabolism; Up regulation; Vehicles
• ISSN: 0036-8075; 1095-9203
• DOI: 10.1126/science.1199498

The mammalian target of rapamycin (mTOR) protein kinase is a master growth promoter that nucleates two complexes, mTORC1 and mTORC2. Despite the diverse processes controlled by mTOR, few substrates are known. We defined the mTOR-regulated phosphoproteome by quantitative mass spectrometry and characterized the primary sequence motif specificity of mTOR using positional scanning peptide libraries. We found that the phosphorylation response to insulin is largely mTOR dependent and that mTOR exhibits a unique preference for proline, hydrophobic, and aromatic residues at the +1 position. The adaptor protein Grb10 was identified as an mTORC1 substrate that mediates the inhibition of phosphoinositide 3-kinase typical of cells lacking tuberous sclerosis complex 2 (TSC2), a tumor suppressor and negative regulator of mTORC1. Our work clarifies how mTORC1 inhibits growth factor signaling and opens new areas of investigation in mTOR biology.